KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Zimmer Biomet Holdings (ZBH) over the last 17 years, with Q3 2025 value amounting to -$163.3 million.

  • Zimmer Biomet Holdings' Cash from Investing Activities fell 542.29% to -$163.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.9 billion, marking a year-over-year decrease of 13785.01%. This contributed to the annual value of -$888.1 million for FY2024, which is 1401.98% down from last year.
  • Per Zimmer Biomet Holdings' latest filing, its Cash from Investing Activities stood at -$163.3 million for Q3 2025, which was down 542.29% from -$1.4 billion recorded in Q2 2025.
  • In the past 5 years, Zimmer Biomet Holdings' Cash from Investing Activities ranged from a high of -$81.1 million in Q1 2022 and a low of -$1.4 billion during Q2 2025
  • Its 5-year average for Cash from Investing Activities is -$225.6 million, with a median of -$154.9 million in 2024.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first soared by 5345.35% in 2021, then crashed by 46048.58% in 2025.
  • Zimmer Biomet Holdings' Cash from Investing Activities (Quarter) stood at -$124.0 million in 2021, then grew by 9.27% to -$112.5 million in 2022, then crashed by 96.27% to -$220.8 million in 2023, then plummeted by 31.88% to -$291.2 million in 2024, then skyrocketed by 43.92% to -$163.3 million in 2025.
  • Its last three reported values are -$163.3 million in Q3 2025, -$1.4 billion for Q2 2025, and -$106.0 million during Q1 2025.